Chime & Waterstone Partner to Advance ADC Development & Manufacture
12 Nov 2024 //
PR NEWSWIRE
Chime Biologics, MedPacto Form Partnership for Biologics
28 Oct 2024 //
PR NEWSWIRE
Chime Biologics Partners For Global Innovation And Quality Enhancement
05 Jul 2024 //
PR NEWSWIRE
Going Global – Chime Biologics Embraces Innovation and Quality with Partners
18 Jun 2024 //
PRESS RELEASE
Domain And Chime Partner To Manufacture Anti-CCR8 Antibody For Cancer
12 Mar 2024 //
PRESS RELEASE
Domain Therapeutics and Chime Biologics announce manufacturing agreement
12 Mar 2024 //
PR NEWSWIRE
Chime Biologics Earns ISO 27001 Cert For CDMO Information Security
07 Mar 2024 //
PRESS RELEASE
Chime Achieves ISO 27001 Certification to Strengthen Information Security
07 Mar 2024 //
PR NEWSWIRE
Chime and Hope Medicine Enter Agreement to Speed up the Launch of HMI-115
26 Oct 2023 //
PR NEWSWIRE
Chime Biologics Partners with Leads Biolabs and BeiGene
30 Jun 2023 //
CONTRACT PHARMA
Chime Biologics Cooperation with Leads Biolabs & BeiGene to Advance LBL-007 mAb
30 Jun 2023 //
PR NEWSWIRE
Chime Biologics Receives Commercial Manufacturing License
02 Aug 2022 //
CONTRACTPHARMA
Chime Biologics Received Commercial Manufacturing License
02 Aug 2022 //
PRNEWSWIRE
EOC Pharma and Chime Biologics Extend Partnership
26 Aug 2021 //
CONTRACTPHARMA
EOC Pharma and Chime Biologics Extend Partnership
26 Aug 2021 //
CONTRACTPHARMA